TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8467308

Group type: EXPERIMENTAL
Intervention: Structured treatment and teaching programme (4 group sessions conducted by paramedical personnel)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (continued hypertension care without the structured programme)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Structured treatment and teaching programme
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 30882137

Group type: EXPERIMENTAL
Intervention: Short-course therapy (median, 9 days; IQR, 8-10)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Long-course therapy (median, 16 days; IQR, 14-17)
Number of subjects: 249
Study: 28959909

Group type: EXPERIMENTAL
Intervention: Whitening toothpaste (specific kind not mentioned)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional non-whitening toothpaste
Number of subjects: 60
Study: 25698156

Group type: EXPERIMENTAL
Intervention: Open arch surgery
Number of subjects: 46

Group type: COMPARATOR
Intervention: Hybrid arch procedure
Number of subjects: 46
Study: 24447425

Group type: EXPERIMENTAL
Intervention: Pegloticase 8 mg every 2 weeks
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Pegloticase 8 mg every 4 weeks
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Pegloticase (both dosing cohorts)
Number of subjects: 103
Study: 22791906

Group type: EXPERIMENTAL
Intervention: Oral cannabis extract (CE) 25 mg daily after titration
Number of subjects: 279

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study: 20436237

Group type: EXPERIMENTAL
Intervention: Active LLLT (cluster probe with 5 laser diodes; lambda = 810 nm; 200 mW power output; 30 seconds of irradiation, applied in 2 locations over the biceps of the nondominant arm; 60 J of total energy)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Active LLLT
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo LLLT
Number of subjects: 9
Study: 16981900

Group type: EXPERIMENTAL
Intervention: 10 mg montelukast daily for 6 days
Number of subjects: 10
Study: 16049631

Group type: COMPARATOR
Intervention: Placebo treatment and counseling with a self-help guide for 7 weeks
Number of subjects: 300
Study: 11801262

Group type: EXPERIMENTAL
Intervention: 10-week relaxation program
Number of subjects: 26

Group type: COMPARATOR
Intervention: Waiting list control (TCs, n=18)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-tinnitus participants (NTPs, n=13)
Number of subjects: 26
Study: 10071523

Group type: EXPERIMENTAL
Intervention: NADH (10 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 7730525

Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) training group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Low-Intensity (LO) training group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (CO) group
Number of subjects: 36
Study: 1787697

Group type: EXPERIMENTAL
Intervention: Keep A Clear Mind (KACM) program
Number of subjects: 511

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 511
Study: 7174213

Group type: EXPERIMENTAL
Intervention: Hospital treatment with short-wave diathermy and daily exercises with graduated weights
Number of subjects: 0

Group type: COMPARATOR
Intervention: Home exercises with graduated weights
Number of subjects: 0
Study: 31084316

Group type: EXPERIMENTAL
Intervention: Children’s Heart Assessment Tool for Transplantation (CHAT) Score
Number of subjects: 5700
Study: 27906448

Group type: EXPERIMENTAL
Intervention: Multicomponent, targeted, low-literacy educational intervention (targeted photonovella booklet/DVD plus FIT kit)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Standard, nontargeted educational intervention (standard CDC brochure plus FIT kit)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Health insurance status
Number of subjects: 416
Study: 26519106

Group type: EXPERIMENTAL
Intervention: STAR training portal (experimental group)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (received access to STAR after the research)
Number of subjects: 142
Study: 28166025

Group type: EXPERIMENTAL
Intervention: Simulation-based workshop
Number of subjects: 27

Group type: COMPARATOR
Intervention: Traditional case-based workshop
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study: 21897852

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 19647921

Group type: EXPERIMENTAL
Intervention: 80 mg atorvastatin daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 17465940

Group type: EXPERIMENTAL
Intervention: Tag on blood bags reminding staff to check the patient's wristband
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (baseline audit period)
Number of subjects: 15
Study: 15085090

Group type: EXPERIMENTAL
Intervention: Ethanol influx (40 g bolus infusion)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ethanol elimination phase
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 20
Study: 12196616

Group type: EXPERIMENTAL
Intervention: Peer counseling
Number of subjects: 794

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Participant-parent contingency contract intervention
Number of subjects: 794
Study: 10436958

Group type: EXPERIMENTAL
Intervention: Xuezhikang (4 capsules/day, 1.2 g/day for 8 weeks)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Simvastatin (Zocor, 10 mg/day for 8 weeks)
Number of subjects: 108
Study: 7635024

Group type: EXPERIMENTAL
Intervention: Routine iron supplements during pregnancy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No iron supplements during pregnancy
Number of subjects: 0
Study: 3284601

Group type: EXPERIMENTAL
Intervention: Progressive Muscular Relaxation (PMR)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (short visit)
Number of subjects: 100
Study: 30376124

Group type: EXPERIMENTAL
Intervention: Individualized Metacognitive Training (MCT+)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cognitive Remediation (CR)
Number of subjects: 54
Study: 27856432

Group type: EXPERIMENTAL
Intervention: Sarilumab (200 mg every 2 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adalimumab (40 mg every 2 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sarilumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 0
Study: 25604769

Group type: EXPERIMENTAL
Intervention: ω3 plus low‐dose aspirin for 6 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 40
Study: 23100188

Group type: EXPERIMENTAL
Intervention: Viscosupplementation with triamcinolone (Group VS + T)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Viscosupplementation alone (Group VS)
Number of subjects: 104
Study: 21859055

Group type: EXPERIMENTAL
Intervention: Postural restrictions after canalith repositioning maneuver (CRM)
Number of subjects: 74

Group type: COMPARATOR
Intervention: No postural restrictions after canalith repositioning maneuver (CRM)
Number of subjects: 74
Study: 19332209

Group type: EXPERIMENTAL
Intervention: Adenosine or regadenoson administration
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 2000

Group type: COMPARATOR
Intervention: DM status
Number of subjects: 2000
Study: 16968790

Group type: EXPERIMENTAL
Intervention: Intrabrachial acetylcholine (Ach) (0.15-15 microg/min.dl) with local vascular COX inhibition by intrabrachial indomethacin (50 microg/min.dl)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Systemic nonselective COX inhibition (100 mg indomethacin)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Selective COX-2 blockade (200 mg celecoxib)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Vitamin C (8 mg/min.dl)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside
Number of subjects: 53

Group type: COMPARATOR
Intervention: L-NMMA (100 microg/min.dl)
Number of subjects: 53
Study: 15517116

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 to 150 mg daily
Number of subjects: 133
Study: 11393553

Group type: EXPERIMENTAL
Intervention: 4 days intravenous insulin infusion annually followed by b.i.d. low doses of subcutaneous ultralente insulin
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Oral insulin
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Nicotinamide
Number of subjects: 552

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 552
Study: 9236642

Group type: EXPERIMENTAL
Intervention: Antenatal perineal massage
Number of subjects: 861
Study: 8003918

Group type: EXPERIMENTAL
Intervention: EEG model sources associated with abstract thoughts
Number of subjects: 12

Group type: COMPARATOR
Intervention: EEG model sources associated with visual imagery
Number of subjects: 12
Study: 2885639

Group type: EXPERIMENTAL
Intervention: 5% glucose polymer solution (302 mOsm/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1.36% glucose solution (332 mOsm/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5% glucose polymer solution
Number of subjects: 0
Study: 30941421

Group type: EXPERIMENTAL
Intervention: Caponization (surgical castration)
Number of subjects: 224
Study: 27583658

Group type: EXPERIMENTAL
Intervention: Tubeless minimally invasive percutaneous nephrolithotomy (MPCNL)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard percutaneous nephrolithotomy (MPCNL)
Number of subjects: 62
Study: 26791478

Group type: EXPERIMENTAL
Intervention: Kundalini yoga programme (15min twice-daily for 12 weeks)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Kundalini yoga programme
Number of subjects: 191
Study: 24361280

Group type: EXPERIMENTAL
Intervention: Gefitinib treatment
Number of subjects: 437

Group type: COMPARATOR
Intervention: Cytology samples
Number of subjects: 437

Group type: COMPARATOR
Intervention: Histology samples
Number of subjects: 437

Group type: COMPARATOR
Intervention: Previous analysis
Number of subjects: 437
Study: 22620695

Group type: EXPERIMENTAL
Intervention: Spinosad at the manufacturer's recommended dose
Number of subjects: 6

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 6
Study: 18836881

Group type: EXPERIMENTAL
Intervention: Joint Crisis Plans (JCPs)
Number of subjects: 160
Study: 17070596

Group type: EXPERIMENTAL
Intervention: Dorzolamide treatment
Number of subjects: 1077

Group type: COMPARATOR
Intervention: Placebo (vehicle of dorzolamide)
Number of subjects: 1077
Study: 11996471

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin/etoposide (PE) followed by hyperfractionated accelerated radiotherapy (HF-RTx; 1.5 Gy bid up to a total dose of 45 Gy in 3 weeks) concurrent with one cycle of PE, and a small volume boost of 20 Gy (qd) for a total of 65 Gy to the primary.
Number of subjects: 30
Study: 10204726

Group type: COMPARATOR
Intervention: Sham heel prick
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Sharp heel prick
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Squeezing the heel for blood sampling
Number of subjects: 23
Study: 7759655

Group type: EXPERIMENTAL
Intervention: Breath sound added to synthetic speech
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breath sound replaced with rustling leaves
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breath sound before randomly selected sentences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breath sound appropriateness to sentence size
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breath sound in experiment 5
Number of subjects: 0
Study: 2676249

Group type: EXPERIMENTAL
Intervention: Normal sodium intake group (44 subjects receiving less than 80 mmol sodium daily in the diet plus 80 mmol of sodium supplement as eight slow release sodium chloride tablets daily)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Low sodium intake group (44 subjects receiving less than 80 mmol sodium daily in the diet plus eight slow release sodium chloride placebo tablets daily)
Number of subjects: 88
Study: 24357

Group type: EXPERIMENTAL
Intervention: 2 mg lorazepam via deep intramuscular injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 mg lorazepam via deep intramuscular injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 mg lorazepam via intravenous injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 mg lorazepam via intravenous injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 mg and 4 mg lorazepam via any route
Number of subjects: 0
Study: 30335625

Group type: EXPERIMENTAL
Intervention: 0.050 μg · kg(‐1) · min(‐1) norepinephrine infusion
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: 0.075 μg · kg(‐1) · min(‐1) norepinephrine infusion
Number of subjects: 284

Group type: COMPARATOR
Intervention: 0.025 μg · kg(‐1) · min(‐1) norepinephrine infusion (control)
Number of subjects: 284
Study: 28777263

Group type: EXPERIMENTAL
Intervention: Enhanced retention package (workflow modifications and active patient tracking)
Number of subjects: 761

Group type: COMPARATOR
Intervention: Control group (no enhanced retention package)
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Birth before ARV pickup
Number of subjects: 761
Study: 25754162

Group type: EXPERIMENTAL
Intervention: Once daily dose of oral isotretinoin
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Twice daily dose of oral isotretinoin
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both regimens of oral isotretinoin
Number of subjects: 58
Study: 24176644

Group type: EXPERIMENTAL
Intervention: Extended release methylphenidate (MPH‐ER) for 24 weeks
Number of subjects: 241
Study: 21546612

Group type: EXPERIMENTAL
Intervention: Tadalafil (5 mg once daily for 90 days)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Endothelial antioxidant compound (EAC) administration after tadalafil discontinuation for 6 months
Number of subjects: 75

Group type: COMPARATOR
Intervention: No other treatment during follow-up after tadalafil cessation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo during follow-up after tadalafil cessation
Number of subjects: 75
Study: 19756033

Group type: EXPERIMENTAL
Intervention: Prior 24-h recalls in the morning for school breakfast
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Prior 24-h recalls in the afternoon for school lunch
Number of subjects: 374

Group type: COMPARATOR
Intervention: Retention interval effect on accuracy
Number of subjects: 374
Study: 17517855

Group type: EXPERIMENTAL
Intervention: Pubovaginal sling using autologous rectus fascia
Number of subjects: 655

Group type: COMPARATOR
Intervention: Burch colposuspension
Number of subjects: 655
Study: 15066454

Group type: COMPARATOR
Intervention: Daily 150 IU recombinant hFSH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent 450 IU recombinant hFSH (3-day intervals)
Number of subjects: 0
Study: 11323351

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 16
Study: 9753341

Group type: EXPERIMENTAL
Intervention: Glucose-based TPN (100% glucose)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Lipid-based TPN (80% lipid, 20% glucose)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 66
Study: 7996375

Group type: EXPERIMENTAL
Intervention: Theo-Dur
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Generic slow-release theophylline tablet
Number of subjects: 38
Study: 2651576

Group type: EXPERIMENTAL
Intervention: PAF (doxorubicin, melphalan, fluorouracil)
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: PFT (doxorubicin, fluorouracil, tamoxifen)
Number of subjects: 1813

Group type: COMPARATOR
Intervention: PF (doxorubicin, fluorouracil)
Number of subjects: 1813

Group type: COMPARATOR
Intervention: PAFT (doxorubicin, melphalan, fluorouracil, tamoxifen)
Number of subjects: 1813
Study: 814956

Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Phenformin
Number of subjects: 118

Group type: COMPARATOR
Intervention: Diet
Number of subjects: 118
Study: 31821732

Group type: EXPERIMENTAL
Intervention: Olaratumab (15 mg/kg) + Doxorubicin (75 mg/m2)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Olaratumab (20 mg/kg) + Doxorubicin (75 mg/m2)
Number of subjects: 49
Study: 30819989

Group type: EXPERIMENTAL
Intervention: Counseling (2 antenatal and 8 postpartum home counseling visits by counselors)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-counseling (Control)
Number of subjects: 300
Study: 27991804

Group type: EXPERIMENTAL
Intervention: Positive anticipated affect manipulation
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Negative anticipated affect manipulation
Number of subjects: 98

Group type: COMPARATOR
Intervention: No affect manipulation control
Number of subjects: 98
Study: 25962070

Group type: EXPERIMENTAL
Intervention: Sparkling white wine (340 mL; 30 g alcohol) in unpleasant ambiance
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Sparkling white wine (340 mL; 30 g alcohol) in pleasant ambiance
Number of subjects: 28

Group type: COMPARATOR
Intervention: Alcohol-free sparkling white wine (340 mL; <2 g alcohol) in unpleasant ambiance
Number of subjects: 28

Group type: COMPARATOR
Intervention: Alcohol-free sparkling white wine (340 mL; <2 g alcohol) in pleasant ambiance
Number of subjects: 28
Study: 24330784

Group type: EXPERIMENTAL
Intervention: High-pitch dual-source CT scan mode
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional dual-source CT scan mode
Number of subjects: 110
Study: 21520432

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV) plus inhaled nitric oxide (iNO)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Pressure-controlled assist/control ventilation (PCACV) plus inhaled nitric oxide (iNO)
Number of subjects: 28
Study: 19389793

Group type: EXPERIMENTAL
Intervention: 50 mg mifepristone every other day for 3 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 18261860

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment for alcohol dependence
Number of subjects: 102

Group type: COMPARATOR
Intervention: Follow-up assessments
Number of subjects: 102
Study: 14984854

Group type: EXPERIMENTAL
Intervention: Ringer's lactate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6% dextran 70
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6% hetastarch
Number of subjects: 40
Study: 11480805

Group type: EXPERIMENTAL
Intervention: Target-absent photo lineup administered by interviewers who were misinformed about the thief's position.
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Testimonies of Experiment 1 witnesses viewed by participant jurors (n = 80).
Number of subjects: 52
Study: 9930385

Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Omeprazole (20 mg daily)
Number of subjects: 14
Study: 8047572

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 37

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 2968267

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30645203

Group type: EXPERIMENTAL
Intervention: BIIB059
Number of subjects: 12
Study: 29638147

Group type: EXPERIMENTAL
Intervention: 20 mEq magnesium L-lactate dihydrate under fasting conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 mEq magnesium L-lactate dihydrate under fed conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: IV infusion of 20 mEq magnesium sulfate
Number of subjects: 0
Study: 27533046

Group type: EXPERIMENTAL
Intervention: M01ZH09
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ty21a
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Pre-existing anti-Vi antibody
Number of subjects: 99
Study: 24962503

Group type: EXPERIMENTAL
Intervention: Call + text message
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Documenting a confidential phone number
Number of subjects: 584

Group type: COMPARATOR
Intervention: Texting only or type of card
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Call + text message with documented confidential phone number
Number of subjects: 584

Group type: COMPARATOR
Intervention: Call or text message (other combinations)
Number of subjects: 584
Study: 22779380

Group type: EXPERIMENTAL
Intervention: Partial soft caries removal at enamel-dentine junction (EDJ) by spoon excavation
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Complete soft caries removal by spoon excavation
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Conventional caries removal by steel burs
Number of subjects: 276
Study: 19157423

Group type: EXPERIMENTAL
Intervention: Polyglytone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Polydioxanone
Number of subjects: 100
Study: 17187606

Group type: EXPERIMENTAL
Intervention: Enhanced nutrition support
Number of subjects: 169

Group type: COMPARATOR
Intervention: Standard nutrition support
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 169
Study: 15237012

Group type: EXPERIMENTAL
Intervention: Multiple transrectal electroejaculations
Number of subjects: 34

Group type: COMPARATOR
Intervention: Single transrectal electroejaculation
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Overall fertilization rate after ICSI
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sperm retrieval success rate
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Number of oocytes retrieved and injected
Number of subjects: 34
Study: 11781912

Group type: EXPERIMENTAL
Intervention: 2.5 mg droperidol intramuscularly
Number of subjects: 29

Group type: COMPARATOR
Intervention: 1.5 mg/kg meperidine intramuscularly
Number of subjects: 29
Study: 9831973

Group type: EXPERIMENTAL
Intervention: Fenofibrate (300 mg daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fenofibrate
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lovastatin
Number of subjects: 100
Study: 8208098

Group type: EXPERIMENTAL
Intervention: Thyropol (thyroid-releasing hormone film)
Number of subjects: 0